Author

E. Korbenfeld

h-index 16 View on Semantic Scholar

We have 2 of 69 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Review Oct 2026

Pembrolizumab Plus Chemotherapy for HR+/HER2- PD-L1‒Positive Advanced Breast Cancer: Final Analysis of the Phase 3 KEYNOTE-B49 Study.

BACKGROUND We evaluated pembrolizumab plus chemotherapy versus chemotherapy alone in participants with PD-L1‒positive, hormone receptor-positive (HR+)/HER2- advanced breast cancer after progression on prior endocrine-based therapy (ET). PATIENTS AND METHODS Participants with locally recurrent inoperable or metastatic...

H. Rugo, M. Kok, A. Gonçalves et al. · Annals of Oncology · 0 citations

Open access Oct 2026

Retrospective analysis of patients with locally advanced or metastatic urothelial carcinoma treated in Argentina (2018–2025): results from the GUIA 2 study in real-world clinical practice

This first multicentre RWE study of la/mUC in Argentina shows treatment patterns and outcomes comparable to international cohorts, and confirms the survival benefit of maintenance therapy and underscores the importance of regional data to optimise urothelial cancer care in Latin America.

Pablo E. Companys, Tomás Soulé, Mariano Aymar et al. · ecancermedicalscience · 0 citations